Filing Details
- Accession Number:
- 0001178913-12-002171
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-07 11:47:24
- Reporting Period:
- 2012-07-31
- Filing Date:
- 2012-08-07
- Accepted Time:
- 2012-08-07 11:47:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1451980 | Biocancell Therapeutics Inc. | BICL | Pharmaceutical Preparations (2834) | 204630076 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1468950 | Ltd. Industries Biotechnology Clal | Hogi Tower, 12A Abba Hillel Silver St. Ramat Gan L3 52506 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-31 | 4,147,171 | $0.22 | 16,591,408 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2012-07-31 | 10,731,726 | $0.22 | 27,323,134 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Debenture | Disposition | 2012-07-31 | 0 | $0.00 | 0 | $0.22 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-07-30 | 2012-07-31 | No | 4 | C | Direct |
Footnotes
- The 4,147,171 shares of Common Stock reported acquired herein are issuable to Clal Biotechnology Industries Ltd. ("CBI") as a result of the conversion of convertible debentures in a principal face amount of $800,000 (the "Debentures") at a conversion price per share of New Israeli Shekel ("NIS") 0.87. Such conversion price is due to adjustments of the initial conversion price of the Debentures, which was initially $0.716, in accordance with the terms of the Debenture. The conversion prices indicated in the table are based on the exchange rate of NIS and US dollar reported by the Bank of Israel on August 3, 2012 (NIS 4.007 for US$1.00).
- The 10,731,726 shares of Common Stock reported acquired herein were acquired through a private placement that was executed in NIS at a price of NIS 0.87 per share. The price indicated in the table is based on the exchange rate of NIS and US dollar reported by the Bank of Israel on August 3, 2012 (NIS 4.007 for US$1.00).